Psyence Biomedical Ltd. Common Shares (PBM NASDAQ) stock market data APIs
$6.1372
0.23(3.7%)
as of May 5, 2026
Try our APIs with
free plan!
Psyence Biomedical Ltd. Common Shares Financial Data Overview
Price chart is built with
Anychart
Psyence Biomedical Ltd. engages in the development of botanical psilocybin-based psychedelic medicines. It also evaluates natural psilocybin for the treatment of adjustment disorder in patients with an incurable cancer diagnosis in a palliative care context. The company's lead product candidate is PEX010, which is in Phase IIb clinical study, a capsule containing naturally sourced psilocybin for treatment of anxiety and depression, including associated ailments, such as post-traumatic stress disorder PTSD, stress, grief, and adjustment disorder in the context of palliative care. It has a partnership with iNGENu Pty Ltd to conduct a Phase IIb clinical trial of PEX010 in psilocybin-assisted psychotherapy for the treatment of AjD due to incurable cancer. The company has a strategic collaboration with PsyLabs to produce Ibogaine. The company is based in Toronto, Canada. Psyence Biomedical Ltd. operates as a subsidiary of Psyence Group Inc.
Prev. Close
6.1372
Open
6.3632
High
6.4068
Low
5.8891
52 wk Range
1.92-74.9375
Market Cap
14 012 K
Shares Outstanding
2 293 K
EPS
-0.51
Beta
1.791
* We provide hundreds of fields of fundamental data, including EBITDA, P/E ratio, PEG ratio, trailing P/E, shareholders, insider transactions, technical metrics, dividends, splits, earnings, and more. Check out our Fundamental Data API.
Why to choose EODHD?
Prices start at $19.99
24/7 Live support
Robust, powerful and reliable data
API Simplicity of a few lines of code
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
Get Psyence Biomedical Ltd. Common Shares data using free add-ons & libraries
Get Psyence Biomedical Ltd. Common Shares Fundamental Data
Psyence Biomedical Ltd. Common Shares Fundamental data includes:
- Net Revenue:
- EBITDA: -4 145 455
- Earnings Per Share:
- Income Statements
- Balance Sheets
- Cash flows
Plans with Fundamental data
Starting from
$
59.99
/mo.
End-of-day & Earnings data
Get Psyence Biomedical Ltd. Common Shares Earnings data
Corporate Events Calendar & News package for
$
19.99
/mo.
What’s included:
- Latest Release: 2025-11-20
- EPS/Forecast: 0
Get Psyence Biomedical Ltd. Common Shares End-of-day data
EOD Historical Data package for
$
19.99
/mo.
What’s included:
- End of Day, Intraday and Live APIs
- Splits
- Dividends
Psyence Biomedical Ltd. Common Shares News
New
Psyence BioMed Positioned as World's only Licensed Pharmaceutical Grade Ibogaine Supplier at Source
NEW YORK, April 20, 2026 (GLOBE NEWSWIRE) -- Psyence Biomedical Ltd. (Nasdaq: PBM) (“Psyence BioMed” or the “Company”), a clinical-stage biopharmaceutical company advancing nature-derived ps...
Psychedelic Shares Rise Following Trump's Executive Order to Accelerate Treatments for Serious Mental Illness
Compass Pathways (CMPS) and other psychedelic shares were up in Monday premarket activity, after US PREMIUM Upgrade to read this MT Newswires article and get so much more. A Silver or Gold subscrip...
Trump Trade: President to sign order on psychedelic used for PTSD
Catch up on the top industries and stocks that were impacted, or were predicted to be impacted, by the comments, actions and policies of President Donald Trump with this daily recap compiled by The Fl...
Sector Update: Health Care Stocks Advance Late Afternoon
Health care stocks climbed late Friday afternoon, with the NYSE Health Care Index rising 1.4% and th PREMIUM Upgrade to read this MT Newswires article and get so much more. A Silver or Gold subscri...
Get Psyence Biomedical Ltd. Common Shares fresh news feed via Financial News API
Corporate Events Calendar & News package for
$19.99/mo.
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
- Flexibility: No long-term commitments, just a minimum of one month
- Instant access: Get your API key and instructions within seconds of subscribing
All-In-One
$99.99/mo.
What’s included:
- API Calls per Day: 100 000/day
- API Requests per Min.: 1000/minute
- Type of Usage: Personal use
Data access:
Historical EOD, Fundamental, Real-Time, Intraday, Live (Delayed), Technical & Screener APIs, News Feed, 40 000 Stock Logos and many more. See a full list.
